Literature DB >> 16822558

Modulation of kinin B1 receptor expression by endogenous angiotensin II in hypertensive rats.

Liliam Fernandes1, Graziela S Ceravolo, Zuleica B Fortes, Rita Tostes, Robson A S Santos, Jerusa A Santos, Marcelo A S Mori, João Bosco Pesquero, Maria Helena C de Carvalho.   

Abstract

We investigated the expression and localization of B1 receptor in tissues of rats submitted to a renin-dependent model of hypertension (2K-1C), and analyzed the influence of endogenous Ang II in modulating the in vivo expression of these receptors. B1 mRNA levels in the heart, kidney and thoracic aorta were quantified by real time PCR, B1 receptor protein expression was assessed by immunohistochemistry, plasma Ang II levels were analyzed by radioimmunoassay and the effects of AT1 receptor blockade were determined after losartan treatment. 2K-1C rats presented a marked increase in Ang II levels when compared to sham-operated rats. In parallel, cardiac- (but not renal and aortic) B1 mRNA levels were 15-fold higher in 2K-1C than in sham rats. In 2K-1C, B1 expression was detected in the endothelium of small cardiac arteries and in cardiomyocytes. Losartan completely reverted the increased B1 mRNA levels and significantly decreased the protein expression observed in 2K-1C rats, despite reducing, but not normalizing blood pressure. We conclude that in the 2K-1C rat, induction of cardiac B1 receptor might be tightly linked to AT1 receptor activation. These data suggest the existence of a new site of interaction between kinins and angiotensins, and might provide important contributions for a better understanding of the pathophysiology of hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822558     DOI: 10.1016/j.regpep.2006.04.018

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

1.  Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension.

Authors:  M E Marketou; J Kontaraki; E Zacharis; F Parthenakis; S Maragkoudakis; I Gavras; H Gavras; P E Vardas
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

2.  Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications.

Authors:  Jenny Pena Dias; Sébastien Talbot; Jacques Sénécal; Pierre Carayon; Réjean Couture
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

3.  Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.

Authors:  Vanessa F Merino; Mihail Todiras; Marcelo A Mori; Vicência M T Sales; Raphael G Fonseca; Vera Saul; Katja Tenner; Michael Bader; João B Pesquero
Journal:  J Mol Med (Berl)       Date:  2009-07-18       Impact factor: 4.599

4.  An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.

Authors:  Graziela S Ceravolo; Augusto C Montezano; Maria T Jordão; Eliana H Akamine; Tiago J Costa; Ana P Takano; Denise C Fernandes; Maria L Barreto-Chaves; Francisco R Laurindo; Rita C Tostes; Zuleica B Fortes; Renato P Chopard; Rhian M Touyz; Maria Helena C Carvalho
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

5.  Angiotensin-Converting Enzyme Inhibitor Protects Against Cisplatin Nephrotoxicity by Modulating Kinin B1 Receptor Expression and Aminopeptidase P Activity in Mice.

Authors:  Gabriel R Estrela; Frederick Wasinski; Marcos F Gregnani; Leandro C Freitas-Lima; Adriano C Arruda; Rafael Leite Morais; Denise Mac Malheiros; Niels O S Camara; João Bosco Pesquero; Michael Bader; Carlos Castilho Barros; Ronaldo Carvalho Araújo
Journal:  Front Mol Biosci       Date:  2020-05-20

6.  Kinin B1 Receptor Blockade Prevents Angiotensin II-induced Neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons.

Authors:  Rohan Umesh Parekh; Jacques Robidoux; Srinivas Sriramula
Journal:  Cell Mol Neurobiol       Date:  2019-12-21       Impact factor: 5.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.